Skip to content

Newsroom

type
year
Illustration image.png

Orion Corporation: Managers’ transactions – Karen Lykke Sørensen

5/4/2026 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Henrik Stenqvist

5/4/2026 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Hilpi Rautelin

5/4/2026 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Veli-Matti Mattila

5/4/2026 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Kari Jussi Aho

5/4/2026 Managers transactions
Illustration image.png

Orion Corporation: Managers’ transactions – Sophie Papa

5/4/2026 Managers transactions
Orion_Asthma_1500x844.jpg

Early diagnosis gives better outcomes – Taking control of asthma from the start

5/3/2026 Your Health
Illustration image.png

Composition of the Nomination Committee of Orion Corporation

4/27/2026 Stock exchange release
Illustration image.png

Orion Group Interim report January–March 2026

4/23/2026 Stock exchange release
Illustration image.png

Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours

4/23/2026 Press release
Illustration image.png

Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA

4/20/2026 Press release
Orionharma_Patient_Journey_Mapping_1500x844.jpg

The patient journey starts with listening: Why the human side of healthcare matters

4/20/2026 Your Health
Illustration image.png

Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026

4/10/2026 Press release
Turun_toimipiste_5_2020.jpg

Orion’s production processes in Turku, Finland to become carbon free with new steam plant

4/9/2026 Sustainability
Orion_Pharmacy careers_1500x844.jpg

Pharmacists at Orion – The many paths a pharmacy degree can open up in the pharmaceutical industry

4/7/2026 We are Orion Pharma
Illustration image.png

Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines

4/1/2026 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

3/31/2026 Flagging notifications
Production_Salo_2024_1920x1080-6.jpg

Medicine deliveries continue despite the conflict in the Middle East

3/27/2026 Orion Pharma and Society